Cargando…
Pharmacogenomics in osteoporosis: Steps toward personalized medicine
Osteoporosis is a complicated and preventable disease with major morbidity complications that affects millions of people. In the last 15 years, there have been numerous studies and research in the new fields of pharmacogenetics and pharmacogenomics related to osteoporosis. Numerous “candidate genes”...
Autores principales: | Greene, Robert, Mousa, Shaymaa S, Ardawi, Mohamed, Qari, Mohamed, Mousa, Shaker A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513203/ https://www.ncbi.nlm.nih.gov/pubmed/23226036 |
Ejemplares similares
-
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
por: Avery, Peter, et al.
Publicado: (2009) -
Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine
por: Barone, Christopher, et al.
Publicado: (2009) -
Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management
por: Rofaiel, Sarah, et al.
Publicado: (2010) -
Pharmacogenomics of sickle cell disease: steps toward personalized medicine
por: Husain, Marium, et al.
Publicado: (2017) -
High Plasma Sphingosine 1-phosphate Levels Predict Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study
por: Ardawi, Mohammed-Salleh M., et al.
Publicado: (2018)